On Tuesday, March 19, the FDA announced approval of (brand name) Zulresso, a first of it’s kind medication for Postpartum Depression. Zulresso (generic name is brexanolone) was developed through clinical trials by pharmaceutical company, Sage Therapeutics. You can find more about the development and history of Zulresso HERE. The medication is potentially a game-changer for...Read More

Fellow providers, please do not stand in the way of your patient receiving mental health services.  There are plenty of obstacles already in the way of individuals finding and engaging with mental health services; other medical providers should not be one of them.  Mental health stigma, lack of awareness or education, fear, cultural biases, finances,...Read More